Beijing Konruns Pharmaceutical Co.,Ltd.’s Net Profit Dropped 26% in 2022

Beijing Konruns Pharmaceutical Co.,Ltd. (北京康辰药业股份有限公司) (603590.SH) reported a net profit of 123.9 million yuan in 2022, down 26% year-on-year.

Meanwhile, the company posted 866.7 million yuan in revenue, up 7% year-on-year.

At the end of the reporting period, it had 3.4 billion yuan in total assets and 234.7 million yuan in total liabilities, with a liability-to-asset ratio of 6.9%.